EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH AND WITHOUT PRIOR COVID-19 INFECTION IN OUTPATIENT VASCULAR SURGERY PRACTICE

Authors

  • М. Hristamyan Department of Epidemiology and Disaster Medicine, Faculty of Public Health, Medical University – Plovdiv Author
  • S. Stanev Clinic of Vascular Surgery, University Hospital “Sv. Georgi” – Plovdiv Author
  • B. Cheshmedzhieva Clinic of Vascular Surgery, University Hospital “Sv. Georgi” – Plovdiv; Clinic of General, Vascular and Abdominal Surgery, Medical Institute of the Ministry of Internal Affairs Author

Keywords:

outpatient medical care, COVID-19, vascular surgery practice, vascular insufficiency, epidemiology

Abstract

Introduction: The COVID-19 pandemic and its multisystemic complications have provoked an increased demand for medical care from various specialists, including vascular surgeons. Aim: To determine the epidemiological characteristics of patients with and without a history of COVID-19 in outpatient vascular surgery practice. Materials and Methods: A retrospective clinicoepidemiological study was conducted in the period 1 January 2021-31 December 2022 (2 years). The study included 1104 patients examined in one vascular surgery practice in prehospital medical care. After anamnesis, a clinical examination and duplex-Doppler sonography were performed in each patient. Statistical analysis was performed with SPSSv.19; a value of p < 0.05 is considered significant. Results: Of all patients aged 13 to 98 years (mean 60.13 years) who visited the practice, 701 (63.5%) were female and 403 (36.5%) were male. In 334 (30.3%), no vascular pathology was found, 770 (69.7%) were diagnosed with peripheral vascular insufficiency, and 47 (4.3%) had lymphedema. One thousand and nine patients (91.4%) denied prior COVID-19, and 95 (8.6%) confirmed having experienced the infection. Peripheral vascular pathology was found in 60 (7.8%) of the patients who had prior COVID-19, and in 35 (10.5%) such pathology was not verified (p > 0.05). In terms of sex distribution, 75 (10.7%) of female patients who survived COVID-19 infection sought outpatient consultation, compared to 20 (5.0%) of examined males (p < 0.05). Patients with a lower than median age who survived COVID-19 demonstrated a significantly higher demand for outpatient vascular surgical care (p < 0.05). Discussion: Many studies demonstrate endothelial damage and microangiopathy, which cannot be registered during clinical examination, but sometimes provoke symptoms resembling macroangiopathy. Gender differences in the immune response after survived infection, as well as vascular recovery, probably account for the higher proportion of female patients. Conclusion: The present study demonstrates a different epidemiological and nosological profile of patients who survived COVID-19, compared to those in hospital care.

References

Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. J Dig Endosc. 2020;11(1):3-7. doi: 10.1055/s-0040-1712187.

Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449-1458. doi: 10.1002/jmv.26424.

Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: an updated review. J Res Med Sci. 2021;26:82. doi: 10.4103/jrms.JRMS_506_20.

Evtugina NG, Sannikova SS, Peshkova AD, et al. Peculiarities of blood coagulation disorders in patients with COVID-19. Ter Arkh. 2021;93(11):1255-1263. doi: 10.26442/00403660.2021.11.201185.

Acharya Y, Alameer A, Calpin G, et al. A comprehensive review of vascular complications in COVID-19. J Thromb Thrombolysis. 2022;53(3):586-593. doi: 10.1007/s11239-021-02593-2.

Mouawad NJ, Woo K, Malgor RD, et al. The impact of the COVID-19 pandemic on vascular surgery practice in the United States. J Vasc Surg. 2021;73(3):772-779.e4. doi: 10.1016/j.jvs.2020.08.036.

Al-Thani H, Mekkodathil A, Hussain A, et al. Implementation of vascular surgery teleconsultation during the COVID-19 pandemic: insights from the outpatient vascular clinics in a tertiary care hospital in Qatar. PLoS One. 2021;16(9):e0257458. doi: 10.1371/journal.pone.0257458.

Hitchman L, Machin M; COVIDSurg Collaborative and Vascular and Endovascular Research Network. Impact of COVID-19 on vascular patients worldwide: analysis of the COVIDSurg data. J Cardiovasc Surg (Torino). 2021;62(6):558-570. doi: 10.23736/S0021-9509.21.12024-5.

Boschetti GA, Di Gregorio S, Mena Vera JM, et al. COVID-19 impact on vascular surgery practice: experience from an Italian university regional hub center for vascular pathology. Ann Vasc Surg. 2021;74:73-79. doi: 10.1016/j.avsg.2021.01.072.

Bryant JM, Boncyk CS, Rengel KF, et al. Association of time to surgery after COVID-19 infection with risk of postoperative cardiovascular morbidity. JAMA Netw Open. 2022;5(12):e2246922. doi: 10.1001/jamanetworkopen.2022.46922.

Batta Y, King C, Johnson J, et al. Sequelae and comorbidities of COVID-19 manifestations on the cardiac and the vascular systems. Front Physiol. 2022;12:748972. doi: 10.3389/fphys.2021.748972.

Zanini G, Selleri V, Roncati L, et al. Vascular „long COVID“: a new vessel disease? Angiology. 2024;75(1):8-14. doi: 10.1177/00033197231153204.

Karakasis P, Nasoufidou A, Sagris M, et al. Vascular alterations following COVID-19 infection: a comprehensive literature review. Life (Basel). 2024;14(5):545. doi: 10.3390/life14050545.

Bruno RM, Badhwar S, Abid L, et al. Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study. Eur Heart J. 2025;46(39):3905-3918. doi: 10.1093/eurheartj/ehaf430.

Ceasovschih A, Sorodoc V, Shor A, et al. Distinct features of vascular diseases in COVID-19. J Inflamm Res. 2023;16:2783-2800. doi: 10.2147/JIR.S417691.

Hockham C, Linschoten M, Asselbergs FW, et al. CAPACITY-COVID Collaborative Consortium. Sex differences in cardiovascular complications and mortality in hospital patients with covid-19: registry based observational study. BMJ Med. 2023;2(1):e000245. doi: 10.1136/bmjmed-2022-000245.

Bielecka-Dabrowa A, Sakowicz A, Kapusta J, et al. The effect of the gender on the risk of long-covid and cardiovascular complications in healthy patients without comorbidities - data from the polish long-COVID cardiovascular (PoLoCOV-CVD) study. Eur Heart J. 2023;44(Suppl 2):ehad655.2629. doi: 10.1093/eurheartj/ehad655.2629.

Sampri A, Shi W, Bolton T, et al. Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records. Lancet Child Adolesc Health. 2025;9(12):837-847. doi: 10.1016/S2352-4642(25)00247-0.

Cholakov A, Petkov A, Chesmedzhieva B, et al. Association between acute arterial or venous thrombosis in active SARS-CoV-2 infection and post-COVID syndrome. Folia Palliatr. 2021;(2):25-29.

Aljadah M, Khan N, Beyer AM, et al. Clinical implications of COVID-19-related endothelial dysfunction. JACC Adv. 2024;3(8):101070. doi: 10.1016/j.jacadv.2024.101070.

Siddiqi HK, Libby P, Ridker PM. COVID-19 – a vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5. doi: 10.1016/j.tcm.2020.10.005

Downloads

Published

05.08.2026

Issue

Section

Original articles

How to Cite

EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH AND WITHOUT PRIOR COVID-19 INFECTION IN OUTPATIENT VASCULAR SURGERY PRACTICE (Hristamyan М. ., S. . Stanev, & B. Cheshmedzhieva , Trans.). (2026). General Medicine, 28(4), 33-38. https://journals.mu-sofia.bg/index.php/gm/article/view/1061

Most read articles by the same author(s)

Similar Articles

1-10 of 29

You may also start an advanced similarity search for this article.